forked from FDA/open.fda.gov
-
Notifications
You must be signed in to change notification settings - Fork 1
/
data.json
3377 lines (3377 loc) · 152 KB
/
data.json
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
{
"conformsTo": "https://project-open-data.cio.gov/v1.1/schema",
"dataset": [
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "This list includes human and pet food subject to recall in the United States since January 2009 related to peanut products distributed by Peanut Corporation of America. ",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/peanutbutterrecall/PeanutButterProducts2009.xml",
"mediaType": "application/xml",
"accessURL": "http://www.accessdata.fda.gov/scripts/peanutbutterrecall/PeanutButterProducts2009.xml",
"downloadURL": "http://www.accessdata.fda.gov/scripts/peanutbutterrecall/PeanutButterProducts2009.xml",
"format": "XML"
}
],
"accrualPeriodicity": "irregular",
"identifier": "5d4b366c-07ca-4358-a783-01aa2fe59684",
"keyword": [
"recalls"
],
"modified": "1900-01-01",
"programCode": [
"009:001"
],
"publisher": {
"name": "Office of Regulatory Affairs",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Peanut Product Recalls",
"landingPage": "http://www.accessdata.fda.gov/scripts/peanutbutterrecall/PeanutButterProducts2009.xml"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "This list includes food subject to recall in the United States since March 2009 related to pistachios distributed by Setton Pistachio of Terra Bella, Inc. The FDA has completed its inspection of Salmonella contamination in pistachios and pistachio products involved in this recall. ",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/pistachiorecall/Pistachio2009.xml",
"mediaType": "application/xml",
"accessURL": "http://www.accessdata.fda.gov/scripts/pistachiorecall/Pistachio2009.xml",
"downloadURL": "http://www.accessdata.fda.gov/scripts/pistachiorecall/Pistachio2009.xml",
"format": "XML"
}
],
"accrualPeriodicity": "irregular",
"identifier": "8acf8bd4-3c2b-4697-a2be-3d5006fbfc91",
"keyword": [
"ora"
],
"modified": "1900-01-01",
"programCode": [
"009:001"
],
"publisher": {
"name": "Office of Regulatory Affairs",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Pistachio Product Recalls",
"landingPage": "http://www.accessdata.fda.gov/scripts/pistachiorecall/Pistachio2009.xml"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "This list includes products subject to recall in the United States since February 2010 related to hydrolyzed vegetable protein (HVP) paste and powder distributed by Basic Food Flavors, Inc. HVP is a flavor enhancer used in a wide variety of processed food products such as soups, sauces, chilis, stews, hot dogs, gravies, seasoned snack foods, dips, and dressings. ",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/HVPCP/HydrolyzedVegetableProteinProductsList2010.xml",
"mediaType": "application/xml",
"accessURL": "http://www.accessdata.fda.gov/scripts/HVPCP/HydrolyzedVegetableProteinProductsList2010.xml",
"downloadURL": "http://www.accessdata.fda.gov/scripts/HVPCP/HydrolyzedVegetableProteinProductsList2010.xml",
"format": "XML"
}
],
"accrualPeriodicity": "irregular",
"identifier": "0a235bac-418f-4fa9-81b7-1af3259a54b1",
"keyword": [
"recalls"
],
"modified": "1900-01-01",
"programCode": [
"009:001"
],
"publisher": {
"name": "Office of Regulatory Affairs",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Hydrolyzed Vegetable Protein Containing Products Recalls",
"landingPage": "http://www.accessdata.fda.gov/scripts/HVPCP/HydrolyzedVegetableProteinProductsList2010.xml"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "Epidemiologic investigations conducted by health officials in California, Colorado, and Minnesota revealed several restaurants or events where more than one person who fell ill with Salmonella Enteriditis had eaten. Information from these investigations suggested that shell eggs were the likely source of infections in many of these restaurants or events. And on August 13, 2010, Wright County Egg of Galt, Iowa, conducted a nationwide voluntary recalls of shell eggs that it had shipped since May 19, 2010. ",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/shelleggsrecall/ShellEggsRecallList2010.xml",
"mediaType": "application/xml",
"accessURL": "http://www.accessdata.fda.gov/scripts/shelleggsrecall/ShellEggsRecallList2010.xml",
"downloadURL": "http://www.accessdata.fda.gov/scripts/shelleggsrecall/ShellEggsRecallList2010.xml",
"format": "XML"
}
],
"accrualPeriodicity": "irregular",
"identifier": "2e20dcb3-74a1-46e1-a7bd-900b78dd0355",
"keyword": [
"recalls"
],
"modified": "1900-01-01",
"programCode": [
"009:001"
],
"publisher": {
"name": "Office of Regulatory Affairs",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Shell Egg Recalls",
"landingPage": "http://www.accessdata.fda.gov/scripts/shelleggsrecall/ShellEggsRecallList2010.xml"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "FDA Enterprise Data Inventory",
"hasEmail": "mailto:[email protected]"
},
"description": "This system is a searchable repository of food code interpretations. There are no exportable data sets. All reports are in PDF format. ",
"distribution": [
{
}
],
"identifier": "TBD by HHS",
"keyword": [
"food",
"code",
"interpretations"
],
"modified": "2015-01-01",
"programCode": [
"009:001"
],
"publisher": {
"name": " Center for Food Safety and Applied Nutrition",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Food Code Reference System"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "FDA Enterprise Data Inventory",
"hasEmail": "mailto:[email protected]"
},
"description": "This system shares public data that can be downloaded. ",
"distribution": [
{
}
],
"identifier": "8DFE05EA-9FA0-4DB8-B803-D3AA70564592",
"keyword": [
"Web Modules"
],
"modified": "2014-09-12",
"programCode": [
"009:001"
],
"publisher": {
"name": " Center for Food Safety and Applied Nutrition",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "CFSAN Web Modules"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "FDA Enterprise Data Inventory",
"hasEmail": "mailto:[email protected]"
},
"description": "This system supports the Information Center's Help Desk capabilities, and reports can be exported. ",
"distribution": [
{
}
],
"identifier": "A6EEDE4E-01A2-4167-A196-87066F135C34",
"keyword": [
"Information Center; Foods Help Desk"
],
"modified": "2014-12-01",
"programCode": [
"009:001"
],
"publisher": {
"name": " Center for Food Safety and Applied Nutrition",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "CFSAN Knowledge Management System [is this salesforce?]"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "This list includes products subject to recall since September 2010 related to infant formula distributed by Abbott. This list will be updated with publicly available information as received. The information is current as of the date indicated. If we learn that any information is not accurate, we will revise the list as soon as possible. When available, this database also includes photos of recalled products that have been voluntarily submitted by recalling firms to the FDA to assist the public in identifying those products that are subject to recall.",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/infantformula/InfantFormulaRecallList2010.xml",
"mediaType": "application/xml",
"accessURL": "http://www.accessdata.fda.gov/scripts/infantformula/InfantFormulaRecallList2010.xml",
"downloadURL": "http://www.accessdata.fda.gov/scripts/infantformula/InfantFormulaRecallList2010.xml",
"format": "XML"
}
],
"accrualPeriodicity": "irregular",
"identifier": "cbb45912-ca03-4398-8d6d-607e335a8ed9",
"keyword": [
"recalls"
],
"modified": "1900-01-01",
"programCode": [
"009:001"
],
"publisher": {
"name": "Office of Regulatory Affairs",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Abbott Infant Formula Recall",
"landingPage": "http://www.accessdata.fda.gov/scripts/infantformula/InfantFormulaRecallList2010.xml"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "MedWatch alerts provide timely new safety information on human drugs, medical devices, vaccines and other biologics, dietary supplements, and cosmetics. The alerts contain actionable information that may impact both treatment and diagnostic choices for healthcare professional and patient.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/UCM189811.zip",
"mediaType": "application/zip",
"accessURL": "http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/UCM189811.zip",
"downloadURL": "http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/UCM189811.zip",
"format": "ZIP"
}
],
"accrualPeriodicity": "R/P1Y",
"identifier": "2003711a-3d1c-4a0c-9928-09de5c42e2cf",
"keyword": [
"definitions"
],
"modified": "R/P1Y",
"programCode": [
"009:008"
],
"publisher": {
"name": "Office of the Commissioner",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "MedWatch Safety Alerts for Human Medical Products",
"landingPage": "http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/default.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "FDA Enterprise Data Inventory",
"hasEmail": "mailto:[email protected]"
},
"description": "Public access allowing for public search of the FDA Adverse Events Database",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/ucm082193",
"mediaType": "text/xml",
"accessURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/ucm082193",
"downloadURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/ucm082193",
"format": "XML"
}
],
"identifier": "901A022F-A9B2-4B0A-9A33-0F3D353DF3FD",
"keyword": [
"FAERS"
],
"modified": "2014-12-31",
"programCode": [
"009:002"
],
"publisher": {
"name": "OSE CDER",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Public Search for Adverse Events (FOIA)"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "Robert Reinwald",
"hasEmail": "mailto:[email protected]"
},
"description": "The Approved Drug Products with Therapeutic Equivalence (Orange Book or OB) is a list of drugs approved under Section 505 of the Federal Food, Drug and Cosmetic Act and provides consumers timely updates on these products. In addition to these products (fo",
"distribution": [
{
}
],
"identifier": "5E4326F3-B3EC-40C7-B5B9-1115F3394E94",
"keyword": [
"Orange Book",
"Approved Drug Products with Therapuetic Equivalence Evaluations"
],
"modified": "2014-01-08",
"programCode": [
"009:002"
],
"publisher": {
"name": "Food and Drug Administration",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Orange Book"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "Rajan, Velayudhan",
"hasEmail": "mailto:[email protected]"
},
"description": "The Global Unique Device Identification Database (GUDID) contains key device identification information submitted to the FDA about medical devices that have Unique Device Identifiers (UDI). Unique device identification is a system being established by the",
"distribution": [
{
}
],
"identifier": "C37E5FDF-6717-4AB3-8585-1808C7BF3B3B",
"keyword": [
"cdrh",
"udi",
"gudid"
],
"modified": "2014-02-04",
"programCode": [
"009:005"
],
"publisher": {
"name": " Center for Devices and Radiological Health",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "GUDID Download"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "Danny Hsu",
"hasEmail": "mailto:[email protected]"
},
"description": "Harmful and Potentially Harmful Constituents",
"distribution": [
{
}
],
"identifier": "96E5B59F-286A-4127-A6E1-82EBA4981EFF",
"keyword": [
"HPHC",
"Harmful",
"Constituents"
],
"modified": "2015-02-03",
"programCode": [
"009:007"
],
"publisher": {
"name": " Food and Drug Administration",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Harmful and Potentially Harmful Constituents"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "This application provides information for active, inactive, and pre-registered firms. Query options are by FEI, Applicant Name, Establishment Name, Other Names, Establishment Type, Establishment Status, City, State, Zip Code, Country and Reporting Official First Name or Last Name.",
"distribution": [
{
"downloadURL": "https://www.accessdata.fda.gov/scripts/cber/CFAppsPub/",
"mediaType": "text/html",
"accessURL": "https://www.accessdata.fda.gov/scripts/cber/CFAppsPub/",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cber/CFAppsPub/",
"format": "Interactive on-screen"
}
],
"identifier": "a0710f78-0585-45c8-9320-7d252b291390",
"keyword": [
"cber"
],
"modified": "2010-06-04",
"programCode": [
"009:003"
],
"publisher": {
"name": "Center for Biologics Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Blood Establishment Registration Database",
"landingPage": "https://www.accessdata.fda.gov/scripts/cber/CFAppsPub/"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "Provides information to the public on postmarket requirements and commitments. The phrase postmarket requirements and commitments refers to studies and clinical trials that sponsors conduct after approval to gather additional information about a product's safety, efficacy, or optimal use. Some of the studies and clinical trials may be required; others may be studies or clinical trials a sponsor has committed to conduct.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Post-marketingPhaseIVCommitments/ucm070777.htm",
"mediaType": "text/html",
"accessURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Post-marketingPhaseIVCommitments/ucm070777.htm",
"downloadURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Post-marketingPhaseIVCommitments/ucm070777.htm",
"format": "Interactive on-screen"
}
],
"identifier": "bf085673-ae08-4807-8ca7-aeb36dde83ed",
"keyword": [
"cder"
],
"modified": "2011-02-10",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Postmarket Requirements and Commitments",
"landingPage": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm142931.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "According to 21 CFR 210.3(b)(8), an inactive ingredient is any component of a drug product other than the active ingredient. Only inactive ingredients in the final dosage forms of drug products are in this database.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm113978.htm",
"mediaType": "application/zip",
"accessURL": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm113978.htm",
"downloadURL": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm113978.htm",
"format": "Zip"
}
],
"identifier": "61f4a54b-daf5-4eb0-82fa-30dc89cd9699",
"keyword": [
"cder"
],
"modified": "2013-01-02",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Inactive ingredient Search for Approved Drug Products",
"describedBy": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm",
"landingPage": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm080123.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "The FDA Adverse Event Reporting System (FAERS) is a database that contains information on adverse event and medication error reports submitted to FDA. The database is designed to support the FDA's post-marketing safety surveillance program for drug and therapeutic biologic products.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm",
"mediaType": "application/zip",
"accessURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm",
"downloadURL": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm",
"format": "Zip"
}
],
"identifier": "c696c4f7-6de9-45db-988a-7195c2ade1d0",
"keyword": [
"cder"
],
"modified": "2013-08-16",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "FDA Adverse Event Reporting System (FAERS): Latest Quartely Data Files",
"landingPage": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "Information about FDA-approved brand name and generic prescription and over-the-counter human drugs and biological therapeutic products. Drugs@FDA includes most of the drug products approved since 1939. The majority of patient information, labels, approval letters, reviews, and other information are available for drug products approved since 1998.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM054599.zip",
"mediaType": "application/zip",
"accessURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM054599.zip",
"downloadURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM054599.zip",
"format": "ZIP"
}
],
"accrualPeriodicity": "R/P1D",
"identifier": "f22c9b6a-e68a-445a-ae44-1441b2f698ab",
"keyword": [
"cder"
],
"modified": "R/P1D",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Drugs@FDA Database",
"describedBy": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm079750.htm",
"landingPage": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135821.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "The Drug Establishments Current Registration Site (DECRS) is a database of current information submitted by drug firms to register establishments (facilities) which manufacture, prepare, propagate, compound or process drugs that are commercially distributed in the U.S. or offered for import to the U.S.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM197817.zip",
"mediaType": "application/zip",
"accessURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM197817.zip",
"downloadURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM197817.zip",
"format": "ZIP"
}
],
"accrualPeriodicity": "R/P3M",
"identifier": "fa27e8ba-4b3c-4a2d-bb29-19eecffa0847",
"keyword": [
"cder"
],
"modified": "R/P3M",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Drug Establishments Current Registration Site",
"landingPage": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135778.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "For a drug product that does not have a dissolution test method in the United States Pharmacopeia (USP), the FDA Dissolution Methods Database provides information on dissolution methods presently recommended by the Division of Bioequivalence, Office of Generic Drugs.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135742.htm",
"mediaType": "text/html",
"accessURL": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135742.htm",
"downloadURL": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135742.htm",
"format": "Interactive on-screen"
}
],
"accrualPeriodicity": "R/P3M",
"identifier": "3f2b8dee-6c80-4230-8f8a-3f7c83920d42",
"keyword": [
"cder"
],
"modified": "R/P3M",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"references": [
"http://www.accessdata.fda.gov/scripts/cder/dissolution/index.cfm"
],
"title": "Dissolution Methods Database",
"landingPage": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135742.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "The Clinical Investigator Inspection List (CLIIL) contains names, addresses, and other pertinent information gathered from inspections of clinical investigators who have performed studies with investigational new drugs. The list contains information on inspections that have been closed since July 1977.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM111343.zip",
"mediaType": "application/zip",
"accessURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM111343.zip",
"downloadURL": "http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM111343.zip",
"format": "Zipped TXT"
}
],
"accrualPeriodicity": "R/P3M",
"identifier": "9dcfa54e-3b0c-40c8-b2fe-754820bed30f",
"keyword": [
"cder"
],
"modified": "R/P3M",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Clinical Investigator Inspector List (CLIIL)",
"describedBy": "http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ucm073059.htm",
"landingPage": "http://www.fda.gov/Drugs/InformationOnDrugs/ucm135198.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "Food producers recall their products from the marketplace when the products are mislabeled or when the food may present a health hazard to consumers because the food is contaminated or has caused a foodborne illness outbreak. ",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Food/RecallsOutbreaksEmergencies/Recalls/default.htm",
"mediaType": "text/html",
"accessURL": "http://www.fda.gov/Food/RecallsOutbreaksEmergencies/Recalls/default.htm",
"downloadURL": "http://www.fda.gov/Food/RecallsOutbreaksEmergencies/Recalls/default.htm",
"format": "On-screen text"
}
],
"identifier": "7268c3d7-607f-452c-a54c-2ac89d7b6b65",
"keyword": [
"cfsan"
],
"modified": "2013-06-06",
"programCode": [
"009:001"
],
"publisher": {
"name": "Center for Food Safety and Applied Nutrition",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Recalls of Food and Dietary Supplements",
"landingPage": "http://www.fda.gov/Food/RecallsOutbreaksEmergencies/Recalls/default.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "The Food and Drug Administration Amendments Act of 2007 gave FDA the authority to require a Risk Evaluation and Mitigation Strategy (REMS) from manufacturers to ensure that the benefits of a drug or biological product outweigh its risks. ",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm",
"mediaType": "application/pdf",
"accessURL": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm",
"downloadURL": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm",
"format": "PDF"
}
],
"identifier": "6c697267-fe17-4c66-8c6d-da38ab9b723b",
"keyword": [
"cder"
],
"modified": "2013-11-12",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Approved Risk Evaluation and Mitigation Strategies",
"landingPage": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable. These drugs include those that are life-supporting, life-sustaining or for use in the prevention or treatment of a debilitating disease or condition, including any such drug used in emergency medical care or during surgery). The discontinuations provided below reflect information received from manufacturers, and are for informational purposes only.",
"distribution": [
{
"downloadURL": "http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm",
"mediaType": "application/unknown",
"accessURL": "http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm",
"downloadURL": "http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm",
"format": "application/unknown"
}
],
"identifier": "6e72c239-0510-49f4-8404-d3d7d50351ec",
"keyword": [
"cder"
],
"modified": "2013-09-26",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Drugs to be Discontinued",
"landingPage": "http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "Information provided to FDA by manufacturers about current drugs in shortage, resolved shortages, and discontinuations of specific drug products.",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm",
"mediaType": "text/html",
"accessURL": "http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm",
"downloadURL": "http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm",
"format": "Interactive on-screen"
}
],
"accrualPeriodicity": "R/P1W",
"identifier": "520f8f0d-b519-4ad9-8597-14d517f00987",
"keyword": [
"cder"
],
"modified": "R/P1W",
"programCode": [
"009:002"
],
"publisher": {
"name": "Center for Drug Evaluation and Research",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"title": "Current and Resolved Drug Shortages and Discontinuations Reported to FDA",
"landingPage": "http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "This database contains a list of classified medical device recalls since November 1, 2002",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm",
"mediaType": "text/html",
"accessURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm",
"downloadURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm",
"format": "Interactive on-screen"
}
],
"identifier": "c2420fb3-2c71-4a09-80a9-5fc2f3a459f5",
"keyword": [
"cdrh"
],
"modified": "2013-11-13",
"programCode": [
"009:005"
],
"publisher": {
"name": "Center for Devices and Radiological Health",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"references": [
"http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm329946.htm"
],
"title": "Medical and Radiation Emitting Device Recalls",
"landingPage": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "The 522 Postmarket Surveillance Studies Program encompasses design, tracking, oversight, and review responsibilities for studies mandated under section 522 of the Federal Food, Drug and Cosmetic Act. The program helps ensure that well-designed 522 postmarket surveillance (PS) studies are conducted effectively and efficiently and in the least burdensome manner.",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss_excel.cfm",
"mediaType": "application/vnd.ms-excel",
"accessURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss_excel.cfm",
"downloadURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss_excel.cfm",
"format": "XLS"
}
],
"identifier": "3d55fceb-5248-4475-b675-503312202d0d",
"keyword": [
"cdrh"
],
"modified": "2013-11-01",
"programCode": [
"009:005"
],
"publisher": {
"name": "Center for Devices and Radiological Health",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"
}
},
"references": [
"http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/PostmarketSurveillance/ucm134497.htm",
"http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm268064.htm"
],
"title": "522 Postmarket Surveillance Studies",
"landingPage": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm"
},
{
"accessLevel": "public",
"bureauCode": [
"009:10"
],
"contactPoint": {
"fn": "openFDA",
"hasEmail": "mailto:[email protected]"
},
"description": "The CDRH Post-Approval Studies Program encompasses design, tracking, oversight, and review responsibilities for studies mandated as a condition of approval of a premarket approval (PMA) application, protocol development product (PDP) application, or humanitarian device exemption (HDE) application. The program helps ensure that well-designed post-approval studies (PAS) are conducted effectively and efficiently and in the least burdensome manner.",
"distribution": [
{
"downloadURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas_Excel.cfm",
"mediaType": "application/vnd.ms-excel",
"accessURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas_Excel.cfm",
"downloadURL": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas_Excel.cfm",
"format": "XLS"
}
],
"identifier": "910c9a83-0447-4c05-b418-c2f49dd83b1b",
"keyword": [
"cdrh"
],
"modified": "2013-11-01",
"programCode": [
"009:005"
],
"publisher": {
"name": "Center for Devices and Radiological Health",
"subOrganizationOf": {
"name": "U.S. Food and Drug Administration"